Put patients first. Put Generics First

If Washington is serious about lowering prescription drug prices and expanding access, quality medicines already available at lower prices should be at the center of the conversation.

Generics need to be first in the affordability conversation, and policy needs to make sure patients can benefit from the competition they create.

Quality medicines at lower prices already exist

Why aren’t generics reaching more patients?

Coverage decisions, regulatory barriers and market incentives can keep affordable medicines out of reach.

Start with what already works

Generics deliver extraordinary value.

89%

of U.S. presriptions are generic.

11.6%

of U.S. presriptions are generic.

$496 B

in healthcare savings in 2025

Generics already play an extraordinary role in American healthcare. The opportunity is to make sure patients receive the full benefit.

AAM’s 2026 Savings Report shows that generic and biosimilar medicines generated $496 Billion in healthcare system savings in 2025 and $3.6 trillion over the past decade. Generics represented 89% of prescriptions filled while accounting for only 11.6% of prescription drug spending.

Start with what already works.

Nearly every conversation about lowering prescription drug prices starts with finding a new solution.

Generics First starts with a proven solution already available.

Different barriers. The same consquence: Patients miss the lower prices competition can deliver.

Lower prescription drug prices?

Start with Generics First

Generics First means removing unnecessary barriers and aligning policies so quality medicines at lower prices can reach the patients who need them.

Quality medicines at lower prices already exist.

It's a question
worth asking.

Generic medicines are a proven solution for lowering prescription drug prices, expanding access and creating competition. But too often, policies and market incentives can stand between patients and the lower-priced medicines already available to them.

It’s time to put Generics First.

Learn More

Explore the issues. Find the facts.

Generic Medicines

Quality, safety, and affordability.

2026 Savings Report

See the economic impact of generics.

Commitment to Quality

How generics are made and monitored.

AAM Advocacy & Policy

Quality, safety, and affordability.